This Ottawa-based company is the first to offer herbs through the Ontario Cannabis Store that won't get you high.

Cannabis accessory brand Ouid (pronounced “weed”) began with a problem.

Week in Weed: Canadian serial entrepreneur Bruce Linton is unapologetically blunt, China’s ancient taste for cannabis, and is this the first U.S. senate race ad featuring pot?

The  Special Access Program by Health Canada was launched last week, giving Canadians access to restricted drugs and psychedelics treatments. But before anyone celebrates, there’s a catch.

BioHarvest Sciences Inc. (CSE: BHSC) has announced its plan to build a production facility in Canada, as part of the next phase in the global expansion of its Cannabis vertical. To that end, the Company is exploring opportunities to acquire an existing licensed facility or a Licensed Producer (LP), which would enable the Company to use its BioFarming technology to produce and then sell unique cannabis products into the Canadian market. (Click here for the Entire Article)

Surplus inventory involves facilities in California, Kentucky and Massachusetts, as well as Ontario, Canada. Liquidation represents buying opportunity for companies in cannabis, pharmaceutical, cosmetics and other industries.

 Tiger Group is selling over 55 million pieces of brand-new hemp CBD wellness products, packaging and related accessories in a major liquidation event.

Worth a total of approximately $15 million at cost, the inventory is available for immediate purchase.

Stephen Kim brings experience in-house at Bayer and Indivior to Avicanna

Police seize a little more than $4,000 in drugs after blast.

A 51-year-old man who was cooking hash oil at a local hotel in Sudbury, Ont. had to receive treatment after his clandestine culinary caper sparked an explosion.

This year will be a big test for cannabis company Sundial Growers (NASDAQ: SNDL). With one recent acquisition closed and another that could be complete in the next few months, the business is undergoing some significant changes that will likely dictate the direction of its share price this year.

In 2021, its stock was up over 400% at one point and ended up finishing the year with a 22% gain -- far better than the Horizons Marijuana Life Sciences ETF, which fell 19%. Can Sundial continue to outperform the broad marijuana index, or will 2022 be a tougher year for the stock?

Why its shares could skyrocket

There are multiple scenarios where I can see Sundial having a great year.

Customs and Border Protection confiscated 6,497 kilograms of weed in fiscal 2021.

The Canada/U.S. border is traditionally a fairly busy place, but the Michigan links have proved a particular hot spot over the last couple of years when it comes to cannabis.

There are now calls for a public inquiry and heightened transparency after a drug and money laundering investigation called “Operation Mad Money” shows links to the Greater Toronto Area (GTA). 

The investigation reveals connections between illegal marijuana sales and Toronto’s red-hot real estate market, as CTV News Toronto reports. 

Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to provide an update on its recent product deliveries for Ontario and Australia.

On January 7, 2022 Canntab completed its first shipment of 5 mg THC tablets to the Ontario Cannabis Store ("OCS"). Additionally, in early December 2021, Canntab completed its second shipment of both THC and CBD tablets to Australia.